Tokyo, Oct 26, 2012 (JCN) - Asahi Kasei's wholly owned US subsidiary ZOLL Medical Corporation (ZOLL) has established Asahi Kasei ZOLL Medical Corporation - its Japanese subsidiary. Asahi Kasei ZOLL Medical, which will commence operations on 5 November 2012, will advance the expansion and development of ZOLL's business in Japan.
ZOLL, a leading US manufacturer of critical care devices and systems, was acquired by Asahi Kasei in line with its target to grow in the critical care segment. As a member company of the Asahi Kasei Group, ZOLL is accelerating the expansion of operations beyond the US and Europe, with a focus on Japan and other major Asian markets.
To further expand its Japanese business, ZOLL is working to obtain regulatory approval as quickly as possible for products currently sold in the US and Europe, while reinforcing its sales infrastructure in the country. Asahi Kasei ZOLL Medical will leverage the resources of the Asahi Kasei Group to facilitate these developments for the swift expansion of ZOLL's business in Japan.
In close collaboration with Admis, Asahi Kasei ZOLL Medical will work to increase sales of the ZOLL AED Plus while advancing preparations for the sale of other approved products such as Thermogard temperature management systems and ZOLL AED Pro automated external defibrillators for use by professional rescuers.
Application has been filed for Japanese regulatory approval of X Series monitor defibrillators and the LifeVest wearable defibrillator.
Copyright © 2013 JCN. All rights reserved. A division of Japan Corporate News Network KK.
 Company Profile |  Print |  Alerts
|
 |
|
Asahi Kasei Establishes Base in India
(Feb 25, 2013)
|
|
|
Asahi Kasei Chemicals Opens AN and MMA Plants in Thailand
(Feb 14, 2013)
|
|
|
Asahi Kasei Completes Construction of Kawasaki Innovation Center
(Dec 3, 2012)
|
|
|
ZOLL Medical Sets Up Japan Subsidiary
(Oct 26, 2012)
|
|
|
Asahi Kasei Microdevices Launches New 3-axis Electronic Compass for Mobile Devices
(July 23, 2012)
|
|
|
Asahi Kasei Medical Takes Equity Stake in NxStage Medical
(May 10, 2012)
|
|
|
Asahi Kasei Commences Tender Offer for ZOLL
(Mar 29, 2012)
|
|
|
Asahi Kasei to Acquire ZOLL Medical
(Mar 14, 2012)
|
|
|
Asahi Kasei Chemicals and Daiso Dissolves JV
(Mar 12, 2012)
|
|
|
Asahi Kasei to Construct Acetonitrile Plant in South Korea
(Mar 6, 2012)
|
|
|
|
|
|
|
Otsuka Launches First Skin Patch Treatment for Parkinson's Disease and Restless Legs Syndrome (Feb 22, 2013)
|
|
|
Teijin Launches Polyester Curtain Fabric with Enhanced Pollen-trapping (Feb 21, 2013)
|
|
|
Toyota Tsusho Opens Medical Clinic in Thai Plant (Feb 18, 2013)
|
|
|
Daiichi Sankyo Develops Nucleic Acid Treatment for Duchenne Muscular Dystrophy (Feb 15, 2013)
|
|
|
Dainippon Sumitomo Pharma Opens Subsidiary in Singapore (Jan 22, 2013)
|
|
|
Teijin and InCube Labs Enter Strategic Partnership in Healthcare Business (Jan 22, 2013)
|
|
|
Chugai Grants Debiopharm Group Exclusive Worldwide License for Anti-cancer Agent (Jan 9, 2013)
|
|
|
Takara Bio Initiates Phase 1 HIV Gene Therapy Clinical Trial (Jan 7, 2013)
|
|
|
Kobe University, KNC Labs and Dainippon Sumitomo to Research Anti-cancer Agent (Dec 28, 2012)
|
|
|
Daiichi Sankyo Introduces Alzheimer's Disease Awareness Campaign (Dec 20, 2012)
|
More Biotech news...
|
|
|
|
|
|
Otsuka Launches First Skin Patch Treatment for Parkinson's Disease and Restless Legs Syndrome (Feb 22, 2013)
|
|
|
Teijin Launches Polyester Curtain Fabric with Enhanced Pollen-trapping (Feb 21, 2013)
|
|
|
Toyota Tsusho Opens Medical Clinic in Thai Plant (Feb 18, 2013)
|
|
|
Daiichi Sankyo Develops Nucleic Acid Treatment for Duchenne Muscular Dystrophy (Feb 15, 2013)
|
|
|
Dainippon Sumitomo Pharma Opens Subsidiary in Singapore (Jan 22, 2013)
|
|
|
Teijin and InCube Labs Enter Strategic Partnership in Healthcare Business (Jan 22, 2013)
|
|
|
Chugai Grants Debiopharm Group Exclusive Worldwide License for Anti-cancer Agent (Jan 9, 2013)
|
|
|
Takara Bio Initiates Phase 1 HIV Gene Therapy Clinical Trial (Jan 7, 2013)
|
|
|
Kobe University, KNC Labs and Dainippon Sumitomo to Research Anti-cancer Agent (Dec 28, 2012)
|
|
|
Daiichi Sankyo Introduces Alzheimer's Disease Awareness Campaign (Dec 20, 2012)
|
More Drugs & OTC news...
|
|
|
|
|
|
Otsuka Launches First Skin Patch Treatment for Parkinson's Disease and Restless Legs Syndrome (Feb 22, 2013)
|
|
|
Teijin Launches Polyester Curtain Fabric with Enhanced Pollen-trapping (Feb 21, 2013)
|
|
|
Toyota Tsusho Opens Medical Clinic in Thai Plant (Feb 18, 2013)
|
|
|
Daiichi Sankyo Develops Nucleic Acid Treatment for Duchenne Muscular Dystrophy (Feb 15, 2013)
|
|
|
Dainippon Sumitomo Pharma Opens Subsidiary in Singapore (Jan 22, 2013)
|
|
|
Teijin and InCube Labs Enter Strategic Partnership in Healthcare Business (Jan 22, 2013)
|
|
|
Chugai Grants Debiopharm Group Exclusive Worldwide License for Anti-cancer Agent (Jan 9, 2013)
|
|
|
Takara Bio Initiates Phase 1 HIV Gene Therapy Clinical Trial (Jan 7, 2013)
|
|
|
Kobe University, KNC Labs and Dainippon Sumitomo to Research Anti-cancer Agent (Dec 28, 2012)
|
|
|
Daiichi Sankyo Introduces Alzheimer's Disease Awareness Campaign (Dec 20, 2012)
|
More Medical news...
|
|
